| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65862-026-10 | 65862-026 | HUMAN PRESCRIPTION DRUG | Lamivudine | Lamivudine | TABLET, FILM COATED | ORAL | 20161121 | N/A | ANDA | ANDA077464 | Aurobindo Pharma Limited | LAMIVUDINE | 300 mg/1 | 3 BLISTER PACK in 1 CARTON (65862-026-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| 65862-026-30 | 65862-026 | HUMAN PRESCRIPTION DRUG | Lamivudine | Lamivudine | TABLET, FILM COATED | ORAL | 20161121 | N/A | ANDA | ANDA077464 | Aurobindo Pharma Limited | LAMIVUDINE | 300 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (65862-026-30) |
| 65862-025-10 | 65862-025 | HUMAN PRESCRIPTION DRUG | Lamivudine | Lamivudine | TABLET, FILM COATED | ORAL | 20161121 | N/A | ANDA | ANDA077464 | Aurobindo Pharma Limited | LAMIVUDINE | 150 mg/1 | 6 BLISTER PACK in 1 CARTON (65862-025-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| 65862-025-60 | 65862-025 | HUMAN PRESCRIPTION DRUG | Lamivudine | Lamivudine | TABLET, FILM COATED | ORAL | 20161121 | N/A | ANDA | ANDA077464 | Aurobindo Pharma Limited | LAMIVUDINE | 150 mg/1 | 60 TABLET, FILM COATED in 1 BOTTLE (65862-025-60) |